治療薬の世界市場分析:製品別(消耗品、機器、データ管理サービス)、技術別(イムノアッセイ、プロテオーム技術)、薬品別(抗てんかん剤、抗生物質、免疫抑制剤、抗不整脈剤)、エンドユーザー別(病院研究室、私設研究室)、セグメント予測...市場調査レポートについてご紹介

【英文タイトル】Therapeutic Drug Monitoring Market Analysis By Product (Consumables, Equipment, Data Management Services), By Technology (Immunoassays, Proteomic Technologies) By Drug Class (Anti-epileptic s, Antibiotics, Immunosuppressants, Anti-arrhythmics) By End-use (Hospital Labs, Private Labs), and Segment Forecasts To 2024

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Content

Chapter 1.Methodology And Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. Therapeutic drug monitoring market – Industry Snapshot and Key Buying Criteria, 2013 – 2024
Chapter 3. Therapeutic Drug Monitoring Market, Industry Outlook
3.1. Market segmentation
3.2. Market size and growth prospects
3.3. Therapeutic drug monitoring market: Market dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Key opportunities prioritized
3.5. Industry Analysis – Porter’s
3.6. Therapeutic drug monitoring market PESTEL analysis, 2015
Chapter 4. Therapeutic Drug Monitoring Market, Product Outlook
4.1. Therapeutic drug monitoring market share by product, 2015 & 2024
4.2. Consumables
4.2.1. Consumables market estimates and forecasts, 2013 – 2024 (USD Million)
4.3. Equipment
4.3.1. Equipment market estimates and forecasts, 2013 – 2024 (USD Million)
4.4. Others
4.4.1. Others market estimates and forecasts, 2013 – 2024 (USD Million)
Chapter 5. Therapeutic Drug Monitoring Market, Technology Outlook
5.1. Therapeutic drug monitoring market share by technology, 2015 & 2024
5.2. Immunoassays
5.2.1. Immunoassays market estimates and forecasts, 2013 – 2024 (USD Million)
5.3. Proteomic technologies
5.3.1. Proteomic technologies market estimates and forecasts, 2013 – 2024 (USD Million)
5.4. Others
5.4.1. Others market estimates and forecasts, 2013 – 2024 (USD Million)
Chapter 6. Therapeutic Drug Monitoring Market, Drug Class Outlook
6.1. Therapeutic drug monitoring market share by drug class, 2015 & 2024
6.2. Anti – epileptics
6.2.1. Anti – epileptic market estimates and forecasts, 2013 – 2024 (USD Million)
6.3. Antibiotics
6.3.1. Antibiotics market estimates and forecasts, 2013 – 2024 (USD Million)
6.4. Immunosuppressants
6.4.1. Immunosuppressants market estimates and forecasts, 2013 – 2024 (USD Million)
6.5. Psychoactive drugs
6.5.1. Psychoactive drugs market estimates and forecasts, 2013 – 2024 (USD Million)
6.6. Anti-arrhythmic drugs
6.6.1. Anti-arrhythmic drugs market estimates and forecasts, 2013 – 2024 (USD Million)
6.7. Others
6.7.1. Others drug market estimates and forecasts, 2013 – 2024 (USD Million)
Chapter 7. Therapeutic Drug Monitoring Market, End – use Outlook
7.1. Therapeutic drug monitoring market share by end – use, 2015 & 2024
7.2. Hospital labs
7.2.1. Hospital labs market estimates and forecasts, 2013 – 2024 (USD Million)
7.3. Private labs
7.3.1. Private labs market estimates and forecasts, 2013 – 2024 (USD Million)
7.4. Others
7.4.1. Others market estimates and forecasts, 2013 – 2024 (USD Million)
Chapter 8. Drug Monitoring Market Regional Outlook
8.1. Therapeutic drug monitoring market share by region, 2015 & 2024
8.2. North America
8.2.1. North America market estimates and forecasts, by product, 2013 – 2024 (USD Million)
8.2.1.1. U.S. market estimates and forecasts
8.2.1.2. Canada market estimates and forecasts
8.2.2. North America market estimates and forecasts, by technology type, 2013 – 2024 (USD Million)
8.2.2.1. U.S. market estimates and forecasts
8.2.2.2. Canada market estimates and forecasts
8.2.3. North America market estimates and forecasts, by drug class, 2013 – 2024 (USD Million)
8.2.3.1. U.S. market estimates and forecasts
8.2.3.2. Canada market estimates and forecasts
8.2.4. North America market estimates and forecasts, by end – use type, 2013 – 2024 (USD Million)
8.2.4.1. U.S. market estimates and forecasts
8.2.4.2. Canada market estimates and forecasts
8.3. Europe
8.3.1. Europe market estimates and forecasts, by product , 2013 – 2024 (USD Million)
8.3.1.1. UK market estimates and forecasts
8.3.1.2. Germany market estimates and forecasts
8.3.2. Europe market estimates and forecasts, by technology, 2013 – 2024 (USD Million)
8.3.2.1. UK market estimates and forecasts
8.3.2.2. Germany market estimates and forecasts
8.3.3. Europe market estimates and forecasts, by drug class, 2013 – 2024 (USD Million)
8.3.3.1. UK market estimates and forecasts
8.3.3.2. Germany market estimates and forecasts
8.3.4. Europe market estimates and forecasts, by end – use, 2013 – 2024 (USD Million)
8.3.4.1. UK market estimates and forecasts
8.3.4.2. Germany market estimates and forecasts
8.4. Asia Pacific
8.4.1. Asia Pacific market estimates and forecasts, by product, 2013 – 2024 (USD Million)
8.4.1.1. Japan market estimates and forecasts
8.4.1.2. China market estimates and forecasts
8.4.2. Asia Pacific market estimates and forecasts, by technology, 2013 – 2024 (USD Million)
8.4.2.1. Japan market estimates and forecasts
8.4.2.2. China market estimates and forecasts
8.4.3. Asia Pacific market estimates and forecasts, by drug class, 2013 – 2024 (USD Million)
8.4.3.1. Japan market estimates and forecasts
8.4.3.2. China market estimates and forecasts
8.4.4. Asia Pacific market estimates and forecasts, by end – use , 2013 – 2024 (USD Million)
8.4.4.1. Japan market estimates and forecasts
8.4.4.2. China market estimates and forecasts
8.5. Latin America
8.5.1. Latin America market estimates and forecasts, by product, 2013 – 2024 (USD Million)
8.5.1.1. Brazil market estimates and forecasts
8.5.2. Latin America market estimates and forecasts, by technology, 2013 – 2024 (USD Million)
8.5.2.1. Brazil market estimates and forecasts
8.5.3. Latin America market estimates and forecasts, by drug class, 2013 – 2024 (USD Million)
8.5.3.1. Brazil market estimates and forecasts
8.5.4. Latin America market estimates and forecasts, by end – use, 2013 – 2024 (USD Million)
8.5.4.1. Brazil market estimates and forecasts
8.6. MEA
8.6.1. MEA market estimates and forecasts, by product , 2013 – 2024 (USD Million)
8.6.1.1. South Africa market estimates and forecast
8.6.2. MEA market estimates and forecasts, by technology, 2013 – 2024 (USD Million)
8.6.2.1. South Africa market estimates and forecast
8.6.3. MEA market estimates and forecasts, by drug class, 2013 – 2024 (USD Million)
8.6.3.1. South Africa market estimates and forecast
8.6.4. MEA market estimates and forecasts, by end – use, 2013 – 2024 (USD Million)
8.6.4.1. South Africa market estimates and forecast
Chapter 9. Competitive Landscape
9.1. Roche Diagnostics
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Strategic Initiatives
9.2. biomérieux, Inc.
9.2.1. Company Overview
9.2.2. Financial Performance
9.2.3. Product Benchmarking
9.2.4. Strategic Initiatives
9.3. Abbott Laboratories, Inc.
9.3.1. Company Overview
9.3.2. Financial Performance
9.3.3. Product Benchmarking
9.3.4. Strategic Initiatives
9.4. Danaher Corporation
9.4.1. Company Overview
9.4.2. Financial Performance
9.4.3. Product Benchmarking
9.4.4. Strategic Initiatives
9.5. Alere, Inc.
9.5.1. Company Overview
9.5.2. Financial Performance
9.5.3. Product Benchmarking
9.5.4. Strategic Initiatives
9.6. Agilent Technologies, Inc.
9.6.1. Company Overview
9.6.2. Financial Performance
9.6.3. Product Benchmarking
9.6.4. Strategic Initiatives
9.7. Thermo Fisher Scientific, Inc.
9.7.1. Company Overview
9.7.2. Financial Performance
9.7.3. Product Benchmarking
9.7.4. Strategic Initiatives
9.8. Siemens Healthcare GmbH
9.8.1. Company Overview
9.8.2. Financial Performance
9.8.3. Product Benchmarking
9.8.4. Strategic Initiatives
9.9. Bio-Rad Laboratories, Inc.
9.9.1. Company Overview
9.9.2. Financial Performance
9.9.3. Product Benchmarking
9.9.4. Strategic Initiatives


【レポート販売概要】

■ タイトル:治療薬の世界市場分析:製品別(消耗品、機器、データ管理サービス)、技術別(イムノアッセイ、プロテオーム技術)、薬品別(抗てんかん剤、抗生物質、免疫抑制剤、抗不整脈剤)、エンドユーザー別(病院研究室、私設研究室)、セグメント予測
■ 英文:Therapeutic Drug Monitoring Market Analysis By Product (Consumables, Equipment, Data Management Services), By Technology (Immunoassays, Proteomic Technologies) By Drug Class (Anti-epileptic s, Antibiotics, Immunosuppressants, Anti-arrhythmics) By End-use (Hospital Labs, Private Labs), and Segment Forecasts To 2024
■ 発行日:2016年8月18日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707842
■ 調査対象地域:グローバル
  • 建築照明の世界市場
    ABSTRACTAbout Architectural Lighting Architectural lighting is defined as lighting, used to illuminate building structures with architectural elements. They are used for both functional and decorative purpose. The architectural lighting market includes lighting applications for indoor lighting and outdoor lighting. The indoor and outdoor segments are the major drivers for the architectural lightin …
  • カポジ肉腫(Kaposi’s Sarcoma):世界の治験レビュー2014年下半期版
    Kaposi's Sarcoma Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Kaposi's Sarcoma Global Clinical Trials Review, H2, 2014" provides data on the Kaposi’s Sarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Kaposi’s Sarcoma. It includes an overview of the trial numbers and their recruitment statu …
  • 世界の遺伝子治療市場予測(~2020)
    Gene therapy is one of the most widely researched fields in the healthcare industry. The high potential of gene therapy to cure various chronic diseases makes it a popular research area. Various researches are being performed across the globe to explore the potential of gene therapy for the treatment of incurable diseases, such as diabetes, cancer, and HIV amongst others. According to RNCOS’ new r …
  • ブロックチェーン技術の世界市場分析:、タイプ別(公共、私用、混合)、用途別(金融サービス、消費者/工業製品、テクノロジー、メディア・テレコム、ヘルスケア、交通、公共部門)、地域別、セグメント予測、2015 – 2024
    The global blockchain technology market is expected to reach USD 7.74 billion by 2024, according to a new report by Grand View Research, Inc. Blockchain is the underlying technology that originated in the form of a public ledger to keep a track of all cryptocurrency transactions. The technology works as an electronic transaction-processing and record-keeping system. This allows various participant …
  • BAW RFフィルタの世界市場2016-2020
    About the Bulk Acoustic Wave (BAW) RF Filter Market BAW filters support RFs in the range of 1.5-16 GHz in mobile devices such as smartphones, tablets, and dongles, as well as Bluetooth devices including GPS. These filters can be small in size or have a lean shape and apply either framework base or ladder formation. Two major types of BAW filters are film bulk acoustic resonators and solid-mounted …
  • IoTセンサの世界市場:圧力、温度、磁気計、加速度計、回転儀、慣性センサ、画像センサ
    The IoT sensors market was valued at USD 3.34 Billion in 2015 and is expected to reach USD 38.41 Billion by 2022, at a CAGR of 42.08% between 2016 and 2022. The growth of the market is driven by the factors such as development of cheaper, smarter, and smaller sensors, growing market for smart devices and wearables, need for real-time computing of applications, supportive government initiatives, de …
  • モバイルウォレットの世界市場2017-2021
    About Mobile Wallets The growing use of 3G and 2G mobile data and broadband globally is a major factor contributing to the growth of the global mobile wallet market. Mobile wallets are equipped with options like integration with coupons and tickets, which are making them highly popular among users. In addition, users can also save their card and bank details on their smartphones and make payments …
  • オタネニンジンの世界市場2015
    Panax Ginseng (CAS 50647-08-0) Market Research Report 2015 aims at providing comprehensive data on Panax Ginseng market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Panax Ginseng description, covers its application areas, manufacturing methods, patterns. It captures Panax Ginseng market trends, pays close attention to Panax Ginseng manufacturers and …
  • Levadex (片頭痛/Migraine):医薬品市場予測及び分析(~2023)
    Levadex (Migraine) - Forecast and Market Analysis to 2023 Summary The migraine market is saturated with generic drugs, and the remaining branded products already on the market are expected to lose exclusivity during the next few years, with the exception of Botox for chronic migraine, which is expected to maintain its leading position in terms of sales. However, reformulations of mature products a …
  • 世界の微生物検査市場
    This 155-page report provides detailed analyses of current and emerging technologies, and their potential applications for the microbiology testing market, including molecular diagnostics, biochips, monoclonal antibodies, immunoassays, IT, gel microdroplets, differential light scattering, chromatography and several others. The report also presents strategic assessments of leading market players an …
  • 弓道具の世界市場2016-2020
    About Archery Equipment Market The global archery equipment market is growing across the globe. In 2015, North America led the market with a 38.04% market share. It was followed by Europe and APAC. The market generated its revenue from the sale of different archery equipment. In 2015, North America dominated the global archery equipment market. This trend is expected to continue during the forecas …
  • 点頭てんかん治療薬の世界市場2017-2021
    About Infantile Spasms Therapeutics An infantile spasm is a particular type of seizure found in an epilepsy syndrome of infancy and childhood. It is also known as a West syndrome. The onset of infantile spasm is usually found in the first year of life between four months and eight months of age. The condition constitutes 2% of childhood epilepsies and 25% of epilepsies with onset in the first year …
  • ドイツのAIDS検査市場2014(DataPack)
    This DataPack presents German test volume and sale forecasts for HIV-1/2, HIV Ag, NAT, Western Blot and other confirmatory assays performed in the following market segments:    - Hospitals    - Commercial/Private Labs     - Blood BanksThe DataPack also provides sales and market share estimates for major suppliers of AIDS tests, including Abbott, Biotest …
  • 粉チーズの世界市場予測(~2022):種類別(チェダー、モッツァレラ、パルメザン、アメリカン、ブルー)、用途別、地域別
    The cheese powder market is projected to grow at a CAGR of 6.82% from 2016 to 2022, to reach a projected value of USD 604.1 Million by 2022. Cheese powder has become prominent in the recent years, due to the increase in size of the convenience & fast food industry and innovative offerings by cheese powder manufacturers. The growth rate in the fast food industry is experiencing a surge due to the c …
  • Dental Caries:グローバル臨床試験レビューH1, 2013
    Dental Caries Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Dental Caries Global Clinical Trials Review, H1, 2013" provides data on the Dental Caries clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dental Caries. It includes an overview of the trial numbers and their recruitment status as per the …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。